Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Head and Neck Cancer

  Free Subscription


25.08.2025

1 Am J Gastroenterol
2 Am J Surg
1 Ann Surg
8 BMC Cancer
1 Br J Cancer
1 Br J Ophthalmol
1 Cancer
2 Cancer Res
1 Clin Cancer Res
1 Dis Esophagus
1 Head Neck
2 Hum Pathol
2 Int J Pediatr Otorhinolaryngol
2 Int J Radiat Oncol Biol Phys
1 J Clin Endocrinol Metab
1 J Laryngol Otol
9 Laryngoscope
24 Oral Oncol
2 PLoS One
2 Radiology
2 Radiother Oncol
1 Surgery
1 Thyroid


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Gastroenterol

  1. SHAH T, Ansari Z, Ahmad A, Coyle W, et al
    Spray Cryotherapy Esophageal Consortium (SPEC) Consensus Recommendations for Liquid Nitrogen Spray Cryotherapy in Barrett's Esophagus and Esophageal Cancer using a Modified Delphi Process.
    Am J Gastroenterol. 2025 Aug 26. doi: 10.14309/ajg.0000000000003752.
    PubMed         Abstract available


    Am J Surg

  2. FINNERTY BM, Marshall T, Annesi CA, Zarnegar R, et al
    Thyroid-stimulating immunoglobulin is not associated with aggressive clinicopathologic features in concomitant Graves' disease and papillary thyroid cancer.
    Am J Surg. 2025;247:116487.
    PubMed         Abstract available

  3. AKINYEMI O, Weldeslase T, Fasokun M, Eze O, et al
    Medicaid expansion and thyroid cancer stage at presentation: A comparative study of two US states.
    Am J Surg. 2025;247:116447.
    PubMed         Abstract available


    Ann Surg

  4. OKUI J, Matsuda S, Nagashima K, Sato Y, et al
    Recurrence-free Survival as a Surrogate Endpoint for Overall Survival in Resectable Esophageal Cancer: Integrated Analysis of Individual Patient Data From Phase III Trials.
    Ann Surg. 2025 Aug 25. doi: 10.1097/SLA.0000000000006919.
    PubMed         Abstract available


    BMC Cancer

  5. LIU L, Liu J, Rong Y, Zhang S, et al
    Comparative study of neoadjuvant chemoradiotherapy, chemotherapy, and chemoimmunotherapy for locally advanced esophageal squamous cell carcinoma.
    BMC Cancer. 2025;25:1320.
    PubMed         Abstract available

  6. MAO Y, Gao Z, Sun Y, Shao C, et al
    Four-year follow-up from the phase 2 study TD-NICE: neoadjuvant treatment of tislelizumab combined with chemotherapy in resectable esophageal squamous cell carcinoma.
    BMC Cancer. 2025;25:1328.
    PubMed         Abstract available

  7. JEONG HJ, Lee JS, Lee JS, Yun HJ, et al
    Anti-thyroglobulin antibody levels post-thyroidectomy and papillary thyroid carcinoma recurrence.
    BMC Cancer. 2025;25:1371.
    PubMed         Abstract available

  8. PANG F, Wu L, Qiu J, Guo Y, et al
    Machine learning models for diagnosing lymph node recurrence in postoperative PTC patients: a radiomic analysis.
    BMC Cancer. 2025;25:1308.
    PubMed         Abstract available

  9. YANG Q, Zhou X, Li J, Wang J, et al
    Comparative analysis and optimization of tumor regression grade assessment systems in neoadjuvant therapy for esophageal squamous cell carcinoma.
    BMC Cancer. 2025;25:1341.
    PubMed         Abstract available

  10. LU Z, Zhu B, Ling H, Chen X, et al
    Deep learning radiomics based on MRI for differentiating tongue cancer T - staging.
    BMC Cancer. 2025;25:1358.
    PubMed         Abstract available

  11. TAN C, Li Y, Jiang C, He L, et al
    DWI-guided DP-IMRT and conventional MRI-based IMRT in head and neck squamous cell carcinoma: a comparative study.
    BMC Cancer. 2025;25:1364.
    PubMed         Abstract available

  12. WU H, Shu W, Ding Y, Li Q, et al
    The immune signatures predict gastric/gastroesophageal junction cancer response to first-line anti-PD-1 blockade or chemotherapy.
    BMC Cancer. 2025;25:1369.
    PubMed         Abstract available


    Br J Cancer

  13. LI Y, Yuan X, Yin XF, Zheng D, et al
    Proteomics analysis and immune profiling reveal regulators of PD-L1 in oesophageal squamous cell carcinoma.
    Br J Cancer. 2025;133:448-463.
    PubMed         Abstract available


    Br J Ophthalmol

  14. FAN W, Jager MJ, Dai W, Heindl LM, et al
    Deep learning-based system for automatic identification of benign and malignant eyelid tumours.
    Br J Ophthalmol. 2025 May 10:bjo-2025-327127. doi: 10.1136/bjo-2025-327127.
    PubMed         Abstract available


    Cancer

  15. BAI M, Lu Y, Shen L, Yin X, et al
    Anti-PD-1 antibody (SCT-I10A) plus anti-EGFR antibody (SCT200) in patients with advanced esophageal squamous cell carcinoma: A multicenter, open-label, phase 1b clinical trial.
    Cancer. 2025;131:e70046.
    PubMed         Abstract available


    Cancer Res

  16. ROY S, Miyauchi S, Jones RN, Kim SS, et al
    HPV E5 Mediates Resistance to Chemotherapy and Radiation by Promoting a Stem Cell-Like Phenotype in Head and Neck Squamous Cell Carcinoma.
    Cancer Res. 2025 Aug 21. doi: 10.1158/0008-5472.CAN-24-3989.
    PubMed         Abstract available

  17. CONTICELLI D, Volante M, Pietrantonio F, Orru C, et al
    AREG and EREG Are Predictive Biomarkers of Response to EGFR Inhibition in Gastroesophageal Cancer.
    Cancer Res. 2025;85:3111-3122.
    PubMed         Abstract available


    Clin Cancer Res

  18. HARING CT, Windon MJ, Heft-Neal ME, Brenner JC, et al
    Toward a Next-Generation Liquid Biopsy for HPV+ HNSCC: Opportunities, Challenges, and the Road Ahead.
    Clin Cancer Res. 2025;31:3359-3361.
    PubMed         Abstract available


    Dis Esophagus

  19. CHEVALLAY M, Barman S, Moss C, Van Hemelrijck M, et al
    Impact of endoscopic pyloric dilatation on symptom relief in delayed gastric emptying after esophageal resection-use of a novel symptom response questionnaire.
    Dis Esophagus. 2025;38:doaf067.
    PubMed         Abstract available


    Head Neck

  20. COGNETTI DM, Curry JM, Johnson J, Kwon M, et al
    Safety and Efficacy Findings From a Phase Ib/II Study of ASP-1929 Photoimmunotherapy With Pembrolizumab in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma.
    Head Neck. 2025 Aug 25. doi: 10.1002/hed.70014.
    PubMed         Abstract available


    Hum Pathol

  21. TANDON A, Sinehaa S, Saifi S, Adhya AK, et al
    BSND: An emerging immunohistochemical marker that reliably distinguishes benign from malignant oncocytic salivary gland tumors.
    Hum Pathol. 2025;161:105870.
    PubMed         Abstract available

  22. YANG D, Li T, Li L, Chen S, et al
    Multi-modal convolutional neural network-based thyroid cytology classification and diagnosis.
    Hum Pathol. 2025;161:105868.
    PubMed         Abstract available


    Int J Pediatr Otorhinolaryngol

  23. MATAN MB, Tahlil AA, Mohamed NA, Tahlil AM, et al
    Laryngeal squamous cell carcinoma in a 4-year-Old child: A rare case report.
    Int J Pediatr Otorhinolaryngol. 2025;196:112482.
    PubMed         Abstract available

  24. NGO QX, Le DT, Ngo DQ
    Risk factors associated with postoperative complications in pediatric thyroidectomy: A single-center Vietnamese experience.
    Int J Pediatr Otorhinolaryngol. 2025;196:112471.
    PubMed         Abstract available


    Int J Radiat Oncol Biol Phys

  25. FAN C, Lee J, Stock S, Woody NM, et al
    Imaging Extranodal Extension (iENE) Predicts Higher Rates of Distant Recurrence for Human Papillomavirus-Positive Oropharyngeal Cancer.
    Int J Radiat Oncol Biol Phys. 2025;123:120-128.
    PubMed         Abstract available

  26. ADRIAN G, Falklind NR, McDowell L, Gebre-Medhin M, et al
    Chemoradiotherapy vs Radiotherapy Alone in T1-2 Oropharyngeal Cancer with Low Volume Neck Disease: A Population-Based Cohort Study Utilizing the XXXXX Head and Neck Cancer Register.
    Int J Radiat Oncol Biol Phys. 2025 Aug 21:S0360-3016(25)06188.
    PubMed         Abstract available


    J Clin Endocrinol Metab

  27. BILGIN C, Hibbert R, Oztepe F, Sfeir JG, et al
    Percutaneous Ablation of Parathyroid Adenomas: A Systematic Review and Meta-Analysis.
    J Clin Endocrinol Metab. 2025;110:e3150-e3162.
    PubMed         Abstract available


    J Laryngol Otol

  28. LEE CW, Jia W, Norman R, Dando A, et al
    Oncological and functional outcomes for transoral robotic surgery versus radiotherapy in T1-2 N0-1 p16+ oropharyngeal carcinoma.
    J Laryngol Otol. 2025;139:730-737.
    PubMed         Abstract available


    Laryngoscope

  29. MEEKS N, McAdoo A, Lee J, Hom M, et al
    Non-FDG-Avid Metastasis Detected by Molecular Imaging in Unknown Primary of the Head and Neck.
    Laryngoscope. 2025;135:3229-3231.
    PubMed         Abstract available

  30. CHEN H, Evans L, Schaaff C, Labib M, et al
    Multidisciplinary Care for Anaplastic Thyroid Cancer-End-of-Life Care as a Standard of Care.
    Laryngoscope. 2025;135:3444-3451.
    PubMed         Abstract available

  31. SALVADOR DM, Welsh CA, Dixon PR
    Large Fibroepithelial Polyp Initially Misdiagnosed as Hemangioma of the Middle Ear Extending Through External Auditory Meatus.
    Laryngoscope. 2025 May 6. doi: 10.1002/lary.32242.
    PubMed         Abstract available

  32. CLARK A, Nam YS, MacKay C, Bullock M, et al
    Assessing the Accuracy, Safety, and Tolerance of Office-Based Endoscopic Biopsies for Laryngopharyngeal Lesions.
    Laryngoscope. 2025;135:3287-3295.
    PubMed         Abstract available

  33. MEEKER MO, Ivancic R, de Silva B, Matrka LA, et al
    Dysplasia and Carcinoma in Recurrent Respiratory Papillomatosis Patients Older Than 45 Years.
    Laryngoscope. 2025;135:3313-3319.
    PubMed         Abstract available

  34. MUELLER-DIESING F, Stoth M, Ludwig E, Rosenwald A, et al
    Moderate Laryngeal Dysplasia in the Context of Classification Systems and Clinical Decision Making.
    Laryngoscope. 2025;135:3296-3305.
    PubMed         Abstract available

  35. FASSLER C, Topf MC, Miller A, Jin W, et al
    Development of a Cutting Guide for Osteocutaneous Radial Forearm Free Flap Harvest.
    Laryngoscope. 2025;135:3149-3157.
    PubMed         Abstract available

  36. KAKI PC, Patel AM, Haleem A, Patel AR, et al
    Adjuvant Radiotherapy in pT1-2N0M0 Head and Neck Adenoid Cystic Carcinoma.
    Laryngoscope. 2025;135:3202-3212.
    PubMed         Abstract available

  37. PARK AC, Fehrenbach MP, Davis RJ, Ayo-Ajibola O, et al
    Social Vulnerability Index as a Tool to Evaluate the Distribution of Head and Neck Oncology Surgeons.
    Laryngoscope. 2025;135:3178-3185.
    PubMed         Abstract available


    Oral Oncol

  38. SCHROTER P, Christ LV, Dvornikovich K, Stritzke F, et al
    Randomized controlled trial of semi-individualized 3D-printed tissue retraction devices vs. standard shielding splints in head and neck cancer treated with intensity-modulated and particle radiotherapy (GUARD).
    Oral Oncol. 2025;169:107604.
    PubMed         Abstract available

  39. ZHANG J, Liu DM
    Advancing self-management for head and neck cancer-related lymphedema: A promising step forward.
    Oral Oncol. 2025;169:107611.
    PubMed         Abstract available

  40. LUO R, Wu J, Zhong W, Ai K, et al
    Letter to the editor - Commentary on "A preliminary exploration of surgical strategies for solitary papillary thyroid carcinoma on the isthmus".
    Oral Oncol. 2025;169:107610.
    PubMed        

  41. CHEN Y, Yan Y
    Comment on "A preliminary exploration of surgical strategies for solitary papillary thyroid carcinoma on the isthmus".
    Oral Oncol. 2025;169:107614.
    PubMed        

  42. DAI Y, Li WJ
    Comment on "Feasibility and preliminary efficacy of a lymphedema and fibrosis self-management program for head and neck cancer survivors: A pilot randomized controlled trial" by Deng J et al.
    Oral Oncol. 2025;169:107613.
    PubMed        

  43. KOLANDHASAMY P
    Letter to the Editor: Oncologic significance of the lateral margin in buccal cancer.
    Oral Oncol. 2025;168:107492.
    PubMed         Abstract available

  44. ZHU L, Jing X, Ahn BC
    Turning tumor microenvironmental foes to friends: A new opportunity for thyroid cancer therapy and redifferentiation.
    Oral Oncol. 2025;168:107513.
    PubMed         Abstract available

  45. MUTHU S
    Commentary on "Histopathological invasion patterns and prognosis in Oral Squamous Cell Carcinoma: A retrospective analysis of 560 cases".
    Oral Oncol. 2025;168:107542.
    PubMed         Abstract available

  46. YANG J, Wu W, Liu J, Li J, et al
    Comprehensive integration of single-cell and bulk transcriptome to reveal plasma cell heterogeneity and a prognosis signature in head and neck squamous cell carcinoma.
    Oral Oncol. 2025;168:107595.
    PubMed         Abstract available

  47. MROSK F, Vertic V, Richter M, Knodler L, et al
    Clinical and oncological outcome in locoregional advanced oral squamous cell carcinoma treated by primary chemoradiation.
    Oral Oncol. 2025;168:107601.
    PubMed         Abstract available

  48. STRUCKMEIER AK, Konig D, Klutmann S, Smeets R, et al
    Sentinel lymph node biopsy in early-stage oral squamous cell carcinoma: clinical outcomes and optimal lymph node removal thresholds.
    Oral Oncol. 2025;168:107598.
    PubMed         Abstract available

  49. BEIRIGER J, Bellamkonda N, White MJ, Liang S, et al
    Implementation of point-of-care genetic testing for head and neck paragangliomas: early experience and future directions.
    Oral Oncol. 2025;168:107600.
    PubMed         Abstract available

  50. GILI R, Morbini P, Bossi P
    PD-L1 Expression in head and neck squamous cell carcinoma: qualitative or quantitative assessment? Is that enough or we need something more?
    Oral Oncol. 2025;168:107606.
    PubMed         Abstract available

  51. PAN CY, Lin TS, Lee TP, Tsai SC, et al
    Transoral robotic surgery in oral tongue cancer patients with trismus: a retrospective evaluation of feasibility and surgical outcomes.
    Oral Oncol. 2025;168:107597.
    PubMed         Abstract available

  52. XU S, Lv Y, He H, Han C, et al
    Immune stratification in HPV-negative HNSCC: prognostic significance and prediction of immunotherapy response.
    Oral Oncol. 2025;168:107605.
    PubMed         Abstract available

  53. NOEL CW, Birkenbeuel J, Ozer E, Agrawal A, et al
    Patterns of referral and outcomes in oropharyngeal cancer management.
    Oral Oncol. 2025;168:107602.
    PubMed         Abstract available

  54. TREECHAIRUSAME T, Singh A, Dee EC, Oh JH, et al
    Osteoradionecrosis as a complication following post-operative intensity-modulated radiation therapy or proton therapy for oral cavity cancer.
    Oral Oncol. 2025;168:107581.
    PubMed         Abstract available

  55. GURIZZAN C, Licata AG, Lorini L, Piazza C, et al
    The interplay of hypoxia, inflammation, and microbiota as indicators of malignant transformation in oral potentially malignant disorders.
    Oral Oncol. 2025;168:107583.
    PubMed         Abstract available

  56. MARQUARDT MD, Freeman T, Pancake A, Lee J, et al
    In-house 3D modeling associated with margin-negative resection in mandibular oral cavity malignancies.
    Oral Oncol. 2025;168:107588.
    PubMed         Abstract available

  57. ABRUZZO AR, Harris MTH, Sroussi HY, Suzuki J, et al
    Oral cavity cancer after sublingual buprenorphine use.
    Oral Oncol. 2025;168:107573.
    PubMed         Abstract available

  58. SOOD R, Singh CA, Panda S, Kakkar A, et al
    Predictors of recurrence, and the impact of adjuvant radiation therapy on survival in early stage (pT1-2, N0) oral cavity squamous cell carcinoma: A matched pair analysis.
    Oral Oncol. 2025;168:107566.
    PubMed         Abstract available

  59. HERMAN M, Michalek J, Pink R, Kopecka K, et al
    Prognostic impact of immune phenotype in oral squamous cell carcinoma.
    Oral Oncol. 2025;168:107568.
    PubMed         Abstract available

  60. KRISHNA R, Kumar P, Urs AB, Mohanty S, et al
    Epithelioid angiosarcoma of the oral cavity: a histopathological and immunohistochemical diagnostic conundrum.
    Oral Oncol. 2025;168:107564.
    PubMed         Abstract available

  61. NARENKUMAR J, Parthipan P
    Letter to the Editor: Impact of the COVID-19 pandemic on diagnosis and disease stage in HPV-positive oropharyngeal cancer: insights and future directions.
    Oral Oncol. 2025;168:107541.
    PubMed         Abstract available


    PLoS One

  62. GAO W, Yuan H, Qing S
    Bioinformatics analysis and experimental validation of the potential relationship between bacterial lipopolysaccharide and oral squamous cell carcinoma.
    PLoS One. 2025;20:e0329231.
    PubMed         Abstract available

  63. CHEN B, Zhan Z, Yu S, Huang J, et al
    Burden of laryngeal cancer attributable to occupational asbestos exposure in China: A comprehensive analysis from 1990 to 2021.
    PLoS One. 2025;20:e0330878.
    PubMed         Abstract available


    Radiology

  64. JABEHDAR MARALANI P, Kang HT
    Middle Neck Involvement: New Layer of Risk Stratification in Nasopharyngeal Carcinoma.
    Radiology. 2025;316:e252512.
    PubMed         Abstract available

  65. QIN GJ, Jiang W, Zhang WQ, Li WF, et al
    MRI-based Middle Neck Involvement in Stage N1-N2 Nasopharyngeal Carcinoma: A Marker for Risk Stratification.
    Radiology. 2025;316:e243399.
    PubMed         Abstract available


    Radiother Oncol

  66. HANSEN CR, Samsoe E, Smulders B, Sand HMB, et al
    Radiotherapy quality assurance of patients with squamous cell carcinoma of the head and neck included in the DAHANCA 19 randomised phase III trial.
    Radiother Oncol. 2025;211:111096.
    PubMed         Abstract available

  67. WONG HCY, Karam I, Corbin K, Tse SSW, et al
    Bao Yuan Gao vs. Calendula cream for radiotherapy-induced skin toxicity in head and neck cancer: A randomized controlled trial - A biased negative trial essentially.
    Radiother Oncol. 2025;211:111109.
    PubMed        


    Surgery

  68. MYLONAKIS A, Dimitrakoudi M, Vasilatou D, Tsapralis D, et al
    Primary esophageal lymphoma: An individual participant data meta-analysis.
    Surgery. 2025;185:109534.
    PubMed         Abstract available


    Thyroid

  69. RINGEL MD, Sosa JA, Baloch Z, Bischoff L, et al
    2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer.
    Thyroid. 2025;35:841-985.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Head and Neck Cancer is free of charge.